Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 2013 and 20Y2, is shown as follows: Dec. 31, 2013 Dec. 31, 20Y2 Assets Cash $310,360 $290,700 Accounts receivable (net) 112,430 104,410 Inventories 317,380 309,120 Investments 0 119,760 Land 162,790 0 350,180 273,300 Equipment Accumulated depreciation-equipment (81,980) (73,700) $1,023,590 Total assets $1,171,160 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Accrued expenses payable (operating expenses) $211,980 $201,650 21,080 26,610 Dividends payable 11,710 9,210 63,240 50,160 Common stock, $10 par Paid-in capital: Excess of issue price over par-common stock Retained earnings 237,750 139,210 625,400 596,750 Total liabilities and stockholders' equity $1,171,160 $1,023,590 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: a. The investments were sold for $140,120 cash. b. Equipment and land were acquired for cash. c. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $76,760 credit to Retained Earnings for net income. f. There was $48,110 debit to Retained Earnings for cash dividends declared. Required: Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments. Livers Inc. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash flows from operating activities: Adjustments to reconcile net income to net cash flow from operating activities: Changes in current operating assets and liabilities: W Net cash flow from operating activities Cash flows from investing activities: Net cash flow used for investing activities Cash flows from financing activities: Net cash flow from financing activities Cash at the beginning of the year Cash at the end of the year